Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05659836 · ClinicalTrials.gov registry record
Spinal Cord Stimulation Trial to Permanent Prediction
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 28
- Enrollment target
NCT05659836: Completed study, sponsored by Abbott Medical Devices.
NCT05659836 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05659836 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
Spinal Cord Stimulation Trial to Permanent Prediction is a prospective, longitudinal, multi-center, non-randomized, multi-arm, open-label, clinical feasibility study designed to investigate whether objective data collected from chronic pain patients is predictive of subjective patient-reported outcomes and of adjustments to patient programming parameters.
Primary Outcome
This exploratory feasibility study seeks to determine whether wearable devices and digital surveys can be used to consistently monitor outcomes from chronic pain patients receiving implanted SCS therapy.
Interventions
- DEVICE Abbott Spinal Cord Stimulation (SCS) Systems (Apple Watch® & Oura™ Ring)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2023-06-15 |
What the finished NCT05659836 record still lists
NCT05659836 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Abbott Spinal Cord Stimulation (SCS) Systems (Apple Watch® & Oura™ Ring) is the first listed.
NCT05659836 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05659836 about?
NCT05659836 is a clinical study titled "Spinal Cord Stimulation Trial to Permanent Prediction". Spinal Cord Stimulation Trial to Permanent Prediction is a prospective, longitudinal, multi-center, non-randomized, multi-arm, open-label, clinical feasibility study designed to investigate whether objective data collected from chronic pain patients is predictive of subjective patient-reported outco...
What is the current status of trial NCT05659836?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2021-05-27. Estimated completion is 2023-06-15.
What interventions are being tested in trial NCT05659836?
The interventions under investigation include: Abbott Spinal Cord Stimulation (SCS) Systems (Apple Watch® & Oura™ Ring) (DEVICE).
Who is sponsoring clinical trial NCT05659836?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI